10x Genomics (NASDAQ:TXG) Price Target Lowered to $14.00 at UBS Group
10x Genomics (NASDAQ:TXG – Free Report) had its price objective decreased by UBS Group from $20.00 to $14.00 in a research report report published on Thursday,Benzinga reports. UBS Group currently has a neutral rating on the stock. A number of other analysts have also recently issued reports on TXG. Citigroup reduced their price objective on […]
10x Genomics (NASDAQ:TXG – Free Report) had its price objective decreased by UBS Group from $20.00 to $14.00 in a research report report published on Thursday,Benzinga reports. UBS Group currently has a neutral rating on the stock. A number of other analysts have also recently issued reports on TXG. Citigroup reduced their price objective on […]
